Alzheimer's disease (AD) is a complicated multifactorial syndrome. Lessons have been
learned through failed clinical trials that targeting multiple key pathways of the AD …

Redox imbalances in the body occur in numerous pathological conditions, such as cancer,
diabetes, wound healing, and neurodegenerative disease. Modulation of this imbalance via …

Therapeutics and biotherapeutics-based fabrication of nanoparticles has fascinated
scientists since the past two decades and exciting challenges have been surmounted …

The current work emphasises on the nanoscale surface designing of Cerium oxide (CeO 2)
nanoparticles in surfactant media. The structural properties of surfactant functionalized …

Engineering of catalytically active inorganic nanomaterials holds promising prospects for
biomedicine. Catalytically active metal oxides show applications in enhancing wound …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by
progressive loss of memory. Presently, AD is challenging to treat with current drug therapy …

In this study, a simple way to produce pegylated ceria nanoparticles (CNPs) with the use of
low-cost and biofriendly starting reagents, such as low molecular Polyethylene Glycol (PEG) …

As we enter the twenty-first century, several therapies based on using nanoparticles (NPs)
ranging in size 1–1000 nm have been successfully brought to the clinic to treat cancer, pain …

Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of liver abnormalities, from
benign steatosis to nonalcoholic steatohepatitis (NASH). Because of their antioxidant …

The application of cerium oxide nanoparticles (CNPs) for therapeutic purposes requires a
stable dispersion of nanoparticles in a biological environment. The objective of this study is …